Ethibond Suture vs Vessel Loop as Draining Seton for Complex Anal Fistulas

Status Not yet recruiting

Clinical Trial Summary

Drainage seton is usually placed for long-term control of symptoms, and hence it has to be effective in drainage of infection, durable, and comfortable to the patients. The present study assumes that different seton materials would attain different drainage capacities, variable durability and impact on QoL. Therefore, the study aims to compare two commonly used seton materials; Ethibond suture and vessel loop, in the management of CAF in terms of effectiveness in draining infection, percent of seton break and its timing, and change in patients' QoL as measured by a validated questionnaire.

Clinical Trial Description

The use of seton as a surgical therapy for fistulous disease has been first described by Hippocrates in 430 BCE. Since then several authors have used either cutting or drainage seton to treat CAF. Different materials have been used as seton, including sutures, stainless steel wires, catheters, cables, silicone, and rubber bands. While the main aim of a drainage seton is to simply drain sepsis and control symptoms in the long term, cutting setons are mainly used for eradiation of the fistula pathology by cutting through the fistula tract and anal sphincter muscles, yet at the cost of an increased risk of fecal incontinence (FI). As the purpose of a drainage seton is to provide long-term, durable drainage of perineal sepsis and control of symptoms, namely discharge, the seton material can have an impact on its function and durability. A review of the variations in seton types and materials showed that the success rates of suture seton (silk, prolene or nylon suture) are higher than those of Penrose drains and catheters. However, there is a paucity of data on the impact of the seton material on the durability of seton and quality of life (QoL) Drainage seton is usually placed for long-term control of symptoms, and hence it has to be effective in drainage of infection, durable, and comfortable to the patients. The present study assumes that different seton materials would attain different drainage capacities, variable durability, and impact on QoL. Therefore, the study aims to compare two commonly used seton materials; Ethibond suture and vessel loop, in the management of CAF in terms of effectiveness in draining infection, percent of seton break and its timing, and change in patients' QoL as measured by a validated questionnaire. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05933343
Study type	Interventional
Source	The Cleveland Clinic
Contact	Sameh H Rizkalla, M.D.
Phone	5513309230
Email	rizkals@ccf.org
Status	Not yet recruiting
Phase	N/A
Start date	July 10, 2023
Completion date	July 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06092398` - Role of Autologous Platelet Rich Plasma(PRP) Injection and Platelet Rich Fibrin Glue(PRFG) Interposition for Treatment of Anal Fistula	N/A
Active, not recruiting	`NCT06243302` - Anal Fistulae Internal Opening Closure by OTSC Clip After Video Assisted Tract Fulguration
Terminated	`NCT02423330` - A Prospective Evaluation of the Strattice-LIFT to Treat Anal Fistula	Early Phase 1
Completed	`NCT01012843` - Do Antibiotics Prevent Anal Fistulae Formation?	N/A
Recruiting	`NCT04750499` - Treatment of Perianal Fistulas by Endorectal Advancement Flap Associated With Adipose Tissue Injection	N/A
Not yet recruiting	`NCT04541238` - Imaging Template for Reporting Anal Fistula
Recruiting	`NCT05044182` - Decompression and Drainage Seton for Treatment of High Horseshoe Anal Fistula	N/A
Recruiting	`NCT03690934` - Treatment of Transsphicteric Fistula-in-ano by Method of Laser Thermoobliteration(FiLaC™).	N/A
Recruiting	`NCT01388257` - Anal Crohn Fistula Surgery	N/A
Active, not recruiting	`NCT00115466` - Autologous Stem Cells Derived From Lipoaspirates for the Non-Surgical Treatment of Complex Perianal Fistula	Phase 2
Not yet recruiting	`NCT03311035` - LIFT Technique Versus Seton in Management of Anal Fistula	N/A
Recruiting	`NCT04790123` - Adipose Tissue Injection for the Treatment of Complex Cryptoglandular Perianal Fistula	N/A
Completed	`NCT05605080` - Hemostatic and Analgesic Effect of Gel Foam and Gauze With Bosmin After Anal Surgery	N/A
Recruiting	`NCT04119700` - Fistulectomy and Primary Sphincter rEconstruction vs. endorectaL Advancement Flap in the Treatment of High Anal Fistulas	N/A
Recruiting	`NCT01997645` - Surgical Treatment of High Perianal Fistulas	N/A
Terminated	`NCT01584752` - Gore-BioA Fistula Plug to Treat Transsphincteric Fistulas
Completed	`NCT04811105` - INVESTIGATION OF THE EFFICACY OF FISTULA OBLITERATION BY STEAM ABLATION IN PERİANAL FISTULAS	N/A
Not yet recruiting	`NCT05476146` - Re-routing in Treatment High Anal Fistula	N/A
Recruiting	`NCT04616911` - Rerouting Seton Versus LIFT for Complex Anal Fistula	N/A
Completed	`NCT03345511` - Ultrasound Guided Caudal Block for Benign Anal Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.